Gabriel’s primary focus within the Global Pricing team is to facilitate UCB’s operational pricing governance so that pricing & patient access excellence is maintained across UCB’s entire branded portfolio. He is primarily responsible for managing, challenging and synthesising affiliate pricing business cases into long term forecasts for global review. In addition, he aids the effective development and implementation of global strategy by acting as a bridge between Global and Local. Gabriel started his career as a scientist researching on various areas, including antibiotic resistance and CAR T cells, in both academia and industry. He graduated in Medical Sciences at University of Exeter Medical School (UK) and his Master’s in Drug Design at University College of London (UK).